BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24952184)

  • 1. Mass spectrometric analysis of post-translational modifications (PTMs) and protein-protein interactions (PPIs).
    Ngounou Wetie AG; Woods AG; Darie CC
    Adv Exp Med Biol; 2014; 806():205-35. PubMed ID: 24952184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometric (MS) Analysis of Proteins and Peptides.
    Jayathirtha M; Dupree EJ; Manzoor Z; Larose B; Sechrist Z; Neagu AN; Petre BA; Darie CC
    Curr Protein Pept Sci; 2021; 22(2):92-120. PubMed ID: 32713333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry for proteomics-based investigation.
    Woods AG; Sokolowska I; Ngounou Wetie AG; Wormwood K; Aslebagh R; Patel S; Darie CC
    Adv Exp Med Biol; 2014; 806():1-32. PubMed ID: 24952176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
    Li J; Zhan X
    Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and Non-proteomics Approaches to Study Stable and Transient Protein-Protein Interactions.
    Ngounou Wetie AG; Sokolowska I; Channaveerappa D; Dupree EJ; Jayathirtha M; Woods AG; Darie CC
    Adv Exp Med Biol; 2019; 1140():121-142. PubMed ID: 31347045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Methods Employed in Mass Spectrometric Analysis of Posttranslational Modifications (PTMs) and Protein-Protein Interactions (PPIs).
    Yakubu RR; Nieves E; Weiss LM
    Adv Exp Med Biol; 2019; 1140():169-198. PubMed ID: 31347048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical advances in proteomics mass spectrometry: identification of post-translational modifications.
    Amoresano A; Carpentieri A; Giangrande C; Palmese A; Chiappetta G; Marino G; Pucci P
    Clin Chem Lab Med; 2009; 47(6):647-65. PubMed ID: 19426139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Posttranslational Modifications (PTMs) of Proteins by Mass Spectrometry.
    Aslebagh R; Wormwood KL; Channaveerappa D; Wetie AGN; Woods AG; Darie CC
    Adv Exp Med Biol; 2019; 1140():199-224. PubMed ID: 31347049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and quantification of protein posttranslational modifications.
    Farley AR; Link AJ
    Methods Enzymol; 2009; 463():725-63. PubMed ID: 19892200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing disease-associated changes in post-translational modifications by mass spectrometry.
    Thygesen C; Boll I; Finsen B; Modzel M; Larsen MR
    Expert Rev Proteomics; 2018 Mar; 15(3):245-258. PubMed ID: 29376447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems-wide proteomic characterization of combinatorial post-translational modification patterns.
    Young NL; Plazas-Mayorca MD; Garcia BA
    Expert Rev Proteomics; 2010 Feb; 7(1):79-92. PubMed ID: 20121478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POTAMOS mass spectrometry calculator: computer aided mass spectrometry to the post-translational modifications of proteins. A focus on histones.
    Vlachopanos A; Soupsana E; Politou AS; Papamokos GV
    Comput Biol Med; 2014 Dec; 55():36-41. PubMed ID: 25450216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic databases and tools to decipher post-translational modifications.
    Kamath KS; Vasavada MS; Srivastava S
    J Proteomics; 2011 Dec; 75(1):127-44. PubMed ID: 21983556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry for Proteomics-Based Investigation.
    Woods AG; Sokolowska I; Ngounou Wetie AG; Channaveerappa D; Dupree EJ; Jayathirtha M; Aslebagh R; Wormwood KL; Darie CC
    Adv Exp Med Biol; 2019; 1140():1-26. PubMed ID: 31347039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase.
    Seo J; Jeong J; Kim YM; Hwang N; Paek E; Lee KJ
    J Proteome Res; 2008 Feb; 7(2):587-602. PubMed ID: 18183946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Top-down Proteomics: Technology Advancements and Applications to Heart Diseases.
    Cai W; Tucholski TM; Gregorich ZR; Ge Y
    Expert Rev Proteomics; 2016 Aug; 13(8):717-30. PubMed ID: 27448560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsynonymous Single-Nucleotide Variations on Some Posttranslational Modifications of Human Proteins and the Association with Diseases.
    Sun B; Zhang M; Cui P; Li H; Jia J; Li Y; Xie L
    Comput Math Methods Med; 2015; 2015():124630. PubMed ID: 26495027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The next level of complexity: crosstalk of posttranslational modifications.
    Venne AS; Kollipara L; Zahedi RP
    Proteomics; 2014 Mar; 14(4-5):513-24. PubMed ID: 24339426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hunting for unexpected post-translational modifications by spectral library searching with tier-wise scoring.
    Ma CW; Lam H
    J Proteome Res; 2014 May; 13(5):2262-71. PubMed ID: 24661115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Software eyes for protein post-translational modifications.
    Na S; Paek E
    Mass Spectrom Rev; 2015; 34(2):133-47. PubMed ID: 24889695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.